http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57169458-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067cda10aaf6d4a5ca8180abe5a545c6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-43
filingDate 1981-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86323401f23d0dbe450350f30e8edb99
publicationDate 1982-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57169458-A
titleOfInvention Preparation of indole derivative
abstract PURPOSE: To obtain the titled compound which is a remedy for arrhythmia, etc. advantageously, by the condensation and ring closure of a specific formylamide compound or a reactive derivative thereof as a raw material in the presence of an alkali metallic compound e.g. CH 3 ONa, and neutralizing the resultant product. n CONSTITUTION: A 5-( 2-methyl-3-formylaminophenyl )-oxymethyl-3-alkyloxazolidin-2-one of formula V (Z is 5-methyl-alkyloxazolidin-2-one) or a reactive derivative thereof is subjected to the condensation and ring closure in the presence of a compound of the formula R 1 OM (R 1 is alkyl, aryl or aralkyl; M is alkali metal), and the resultant 5-(4-indolyloxymethyl)-3-alkyloxazolidone-N 1 -alkali metallic salt of formula II' is neutralized with an acid to afford an indole derivative of formula II. The compound of formula II' is further hydrolyzed to afford a 4-(2-hydroxy-3-alkylaminopropoxy)indole derivative of formulaI. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5863935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5466699-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5399574-A
priorityDate 1981-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70542775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236447122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID534901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236444337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70545200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236434076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605938

Total number of triples: 25.